Montpellier, France

Daniel Latreille



 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Latreille

Introduction

Daniel Latreille is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medical research, particularly in the treatment of retrovirus infections. His work is characterized by a commitment to advancing scientific knowledge and improving therapeutic options for patients.

Latest Patents

Latreille holds a patent for "Compositions and methods for treating retrovirus infections." This invention relates to nucleic acids that can induce HIV-1 expression in latent HIV-1-infected cells. The patent outlines the use of specific sequences and their derivatives for potential use as a medicament, particularly aimed at treating retrovirus infections. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.

Career Highlights

Latreille is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His role there allows him to collaborate with other leading scientists and contribute to groundbreaking research in virology and therapeutics. His dedication to research has positioned him as a key figure in his field.

Collaborations

Throughout his career, Latreille has worked alongside esteemed colleagues such as Monsef Benkirane and Robinson Triboulet. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Daniel Latreille's contributions to the field of retrovirus treatment exemplify the importance of innovation in medical research. His patent and collaborative efforts reflect a commitment to improving health outcomes for individuals affected by viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…